CDKN2A and cancer: Upon exposure to anti-cancer drugs, some cancer cells increased their cell size and survived by stopping or slowing their cell cycle in a DNA damage response involving increased expression of cell cycle inhibitors, including p16Ink4a and p21Cip1/Waf1 [8,9,10].